Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori
- PMID: 21886911
- PMCID: PMC3163361
- DOI: 10.3797/scipharm.1011-05
Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori
Abstract
The present study has been undertaken to apply the concept of nanoparticulate mucopenetrating drug delivery system for complete eradication of Helicobacter pylori (H. pylori), colonised deep into the gastric mucosal lining. Most of the existing drug delivery systems have failed on account of either improper mucoadhesion or mucopenetration and no dosage form with dual activity of adhesion and penetration has been designed till date for treating H. pylori induced disorders. In the present study, novel chitosan-alginate polyelectrolyte complex (CS-ALG PEC) nanoparticles of amoxicillin have been designed and optimized for various variables such as pH and mixing ratio of polymers, concentrations of polymers, drug and surfactant, using 3(3) Box-Behnken design. Various studies like particle size, surface charge, percent drug entrapment, in-vitro mucoadhesion and in-vivo mucopenetration of nanoparticles on rat models were conducted. The optimised FITC labelled CS-ALG PEC nanoparticles have shown comparative low in-vitro mucoadhesion with respect to plain chitosan nanoparticles, but excellent mucopenetration and localization as observed with increased fluorescence in gastric mucosa continuously over 6 hours, which clinically can help in eradication of H. pylori.
Keywords: Box Behnken design; Factorial design; Helicobacter pylori; Mucopenetration; Stomach specific delivery system.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f1.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f2.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f3.gif)
![Fig. 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f4.gif)
![Fig. 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f5.gif)
![Fig. 6.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f6.gif)
![Fig. 7.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f7.gif)
![Fig. 8.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3163361/bin/Scipharm-2011-79-673f8.gif)
Similar articles
-
Mucoadhesive versus mucopenetrating nanoparticles for oral delivery of insulin.Acta Biomater. 2021 Nov;135:506-519. doi: 10.1016/j.actbio.2021.08.046. Epub 2021 Sep 4. Acta Biomater. 2021. PMID: 34487859
-
Recent Advancements in Using Polymers for Intestinal Mucoadhesion and Mucopenetration.Macromol Biosci. 2020 Mar;20(3):e1900342. doi: 10.1002/mabi.201900342. Epub 2020 Feb 11. Macromol Biosci. 2020. PMID: 32045102 Review.
-
The potential utility of chitosan micro/nanoparticles in the treatment of gastric infection.Expert Rev Anti Infect Ther. 2014 Aug;12(8):981-92. doi: 10.1586/14787210.2014.930663. Epub 2014 Jun 30. Expert Rev Anti Infect Ther. 2014. PMID: 24981812 Review.
-
Floating-bioadhesive gastroretentive Caesalpinia pulcherrima-based beads of amoxicillin trihydrate for Helicobacter pylori eradication.Drug Deliv. 2016;23(2):405-19. doi: 10.3109/10717544.2014.916766. Epub 2014 May 28. Drug Deliv. 2016. PMID: 24870198
-
Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion.J Adv Pharm Technol Res. 2012 Jan;3(1):68-74. doi: 10.4103/2231-4040.93555. J Adv Pharm Technol Res. 2012. PMID: 22470897 Free PMC article.
Cited by
-
Amoxicillin-docosahexaenoic acid encapsulated chitosan-alginate nanoparticles as a delivery system with enhanced biocidal activities against Helicobacter pylori and improved ulcer healing.Front Microbiol. 2023 Feb 9;14:1083330. doi: 10.3389/fmicb.2023.1083330. eCollection 2023. Front Microbiol. 2023. PMID: 36846798 Free PMC article.
-
Nano-Encapsulated Antioxidant: Retinoic Acid as a Natural Mucosal Adjuvant for Intranasal Immunization against Chronic Experimental Toxoplasmosis.Trop Med Infect Dis. 2023 Feb 7;8(2):106. doi: 10.3390/tropicalmed8020106. Trop Med Infect Dis. 2023. PMID: 36828522 Free PMC article.
-
Nano-Encapsulated Melatonin: A Promising Mucosal Adjuvant in Intranasal Immunization against Chronic Experimental T. gondii Infection.Trop Med Infect Dis. 2022 Nov 27;7(12):401. doi: 10.3390/tropicalmed7120401. Trop Med Infect Dis. 2022. PMID: 36548656 Free PMC article.
-
Utilization of a nanostructured lipid carrier encapsulating pitavastatin-Pinus densiflora oil for enhancing cytotoxicity against the gingival carcinoma HGF-1 cell line.Drug Deliv. 2023 Dec;30(1):83-96. doi: 10.1080/10717544.2022.2155269. Drug Deliv. 2023. PMID: 36510636 Free PMC article.
-
Gentamicin-Ascorbic Acid Encapsulated in Chitosan Nanoparticles Improved In Vitro Antimicrobial Activity and Minimized Cytotoxicity.Antibiotics (Basel). 2022 Nov 2;11(11):1530. doi: 10.3390/antibiotics11111530. Antibiotics (Basel). 2022. PMID: 36358185 Free PMC article.
References
-
- Murakami K, Okimoto T, Kodama M, Sato R, Miyajima H, Ono M, Inoue K, Watanabe K, Otsu S, Fujioka T. Comparison of Amoxicillin–Metronidazole Plus Famotidine or Lansoprazole for Amoxicillin–Clarithromycin–Proton Pump Inhibitor Treatment Failures for Helicobacter pylori Infection. Helicobacter. 2006;11:436–440. doi: 10.1111/j.1523-5378.2006.00435.x. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources